Moleculin Biotech, Inc. Advances Annamycin for Pediatric Cancer Treatment as FDA Approves Inclusion of Younger Patients in Clinical Study
18/6 13:42
Moleculin Biotech announced FDA approval for a pediatric study of Annamycin, targeting relapsed/refractory acute myeloid leukemia....